Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: Results of treatment with intravesical bacillus Calmette-Guerin

Journal of Urology

Volumn 139, Issue 2, 1988, Pages

  Hillyard, R W ^a   Ladaga, L ^a   Schellhammer, P F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BLADDER CARCINOMA; BLADDER MUCOSA; CLINICAL ARTICLE; CYSTECTOMY; NORMAL HUMAN; PRIORITY JOURNAL; RECURRENT CANCER; SUPERFICIAL CANCER; TOPICAL DRUG ADMINISTRATION; TRANSITIONAL CELL CARCINOMA; URETHRA PROSTATIC PART; URINARY DIVERSION;

EID: 0023849637     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)42389-5     Document Type: Article

References (15)

1. A. Morales D. Eidinger A.W. Bruce Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors J. Urol. 116 1976 180
2. P.F. Schellhammer L.E. Ladaga M.B. Fillion Bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder J. Urol. 135 1986 261
3. S.A. Brosman Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma J. Urol. 128 1982 27
4. J.B. deKernion M.-Y. Huang A. Lindner R.B. Smith J.J. Kaufman Management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin J. Urol. 133 1985 598
5. H.W. Herr C.M. Pinsky W.F. Whitmore Jr. P.G. Sogani H.F. Oettgen M.R. Melamed Experience with intravesical bacillus C almette-Guerin therapy of superficial bladder tumors Urology 25 1985 119
6. D.L. Lamm Bacillus Calmette-Guerin immunotherapy for bladder cancer J. Urol. 134 1985 40
7. E.O. Haaff S.M. Dresner T.L. Ratliff W.J. Catalona Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder J. Urol. 136 1986 820
8. D.R. Kelley E.O. Haaff M. Becich J. Lage W.C. Bauer S.M. Dresner W.J. Catalona T.L. Ratliff Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin J. Urol. 135 1986 268
9. P.F. Schellhammer M.A. Bean W.F. Whitmore Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis J. Urol. 118 1977 399
10. M. Stilmant M.B. Siroky K.B. Johnson Fine needle aspiration of granulomatous prostatitis induced by BCG immunotherapy of bladder cancer Acta Cytol. 29 1985 961
11. D.L. Lamm V.D. Stodgill B.J. Stodgill R.G. Crispen Complications of bacillus Calmette-Guerin immunotherapy in 1, 278 patients with bladder cancer J. Urol. 135 1986 272
12. W.D. Winters D.L. Lamm Antibody responses to bacillus Calmette-Guerin during immunotherapy in bladder cancer patients Cancer Res. 41 1981 2672
13. E.O. Haaff W.J. Catalona T.L. Ratliff Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG J. Urol. 136 1986 970
14. Catalona, W. J., Shapiro, A., Ratliff, T. L. and Oakley, D.: Interferon induction during intravesical bacille Calmette Guerin (BCG) therapy. Proceedings of XIX Congrès de la Société Internationale Urologie, San Francisco, 1982.
15. H.W. Herr C.M. Pinsky W.F. Whitmore Jr. P.C. Sogani H.F. Oettgen M.R. Melamed Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder J. Urol. 135 1986 265